A biomarker survey of urinary deoxynivalenol in China: The Shanghai women's health study

Food Additives and Contaminants - Part A

Volumn 28, Issue 9, 2011, Pages 1220-1223

  Turner, P C ^a   Ji, B T ^b   Shu, X O ^c   Zheng, W ^c   Chow, W H ^b   Gao, Y T ^d   Hardie, L J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d SHANGHAI CANCER INSTITUTE   (China)

Author keywords

Exposure; LC MS; Mycotoxins; Trichothecenes

Indexed keywords

DETOXIFICATION; METABOLITES;

COMBINED MEASURE; ECOLOGICAL SURVEY; ESOPHAGEAL CANCER; EXPOSURE; GLUCURONIDE METABOLITES; LC/MS; MYCOTOXINS; TRICHOTHECENES;

SURVEYS;

BIOLOGICAL MARKER; GLUCURONIDE; VOMITOXIN;

ADULT; AGED; ARTICLE; CHINA; DETOXIFICATION; ESOPHAGUS CANCER; FEMALE; FOOD CONTAMINATION; FOOD POISONING; HUMAN; LONG TERM EXPOSURE; PRIORITY JOURNAL; RACE DIFFERENCE; TOXIN ANALYSIS; UNITED KINGDOM; URINALYSIS; WHEAT;

ANIMALIA; HORDEUM; TRITICUM AESTIVUM; ZEA MAYS;

EID: 80052564196     PISSN: 19440049     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/19440049.2011.584070     Document Type: Article

References (26)

1. Amuzie CJ, Pestka JJ. 2010. Suppression of insulin-like growth factor acid-labile subunit expression-A novel mechanism for deoxynivalenol-induced growth retardation. Toxicol Sci. 113(2):412-421.
2. Bouhet S, Oswald IP. 2005. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet Immunol Immunopathol. 108(1-2):199-209.
3. Canady RA, Coker RD, Egan SK, Krska R, Kuiper- Goodman T, Olsen M, Pestka J, Resnik S, Schlatter J. 2001. Deoxynivalenol. Safety evaluation of certain mycotoxins in food. Geneva (Switzerland): World Health Organization.
4. CAST. 2003. Potential economic costs of mycotoxins in the United States. In: Mycotoxins: risks in plant, animal, and human systems. Task Force Report No. 139. Ames (IA): Council for Agricultural Science and Technology. p. 136-142.
5. Choi HJ, Yang H, Park SH, Moon Y. 2009. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol. Toxicol Appl Pharmacol. 240(1):46-54.
6. Henderson L, Gregory J, Swan G. The national diet and nutrition survey: adults aged 19-64 years 2002. Norwich: HMSO; [cited 2010 April 16]. Available from: http://www.food.gov.uk/multimedia/pdfs/ndnsprintedreport.pdf
7. Hepworth SJ, Hardie LJ, Fraser LK, Burley VJ, Mijal RS, Wild CP, Azad R, McKinney PA, Turner PC. 2011. Deoxynivalenol exposure assessment in a cohort of pregnant women from Bradford, UK. Food Addit Contam A. [Epub ahead of print].
8. Hsia CC, Wu JL, Lu XQ, Li YS. 1988. Natural occurrence and clastogenic effects of nivalenol, deoxynivalenol, 3-acetyl-deoxynivalenol, 15-acetyl-deoxynivalenol, and zearalenone in corn from a high risk area of esophageal cancer. Cancer Detect Prev. 13:79-86
9. Jackson LS, Bullerman LB. 1999. Effect of processing on Fusarium mycotoxins. Adv Exp Med Biol. 459:243-261.
10. Luo X. 1994. Food poisoning caused by Fusarium toxins. Proc Second Asian Conf Food Safety. 2:129-136.
11. Luo Y, Yoshizawa T, Katayama T. 1990. Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high- and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol. 56:3723-3726.
12. Meky FA, Turner PC, Ashcroft AE, Miller JD, Qiao YL, Roth MJ, Wild P. 2003. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol. 41(2):265-273.
13. Pestka JJ, Smolinski AT. 2005. Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Health B Crit Rev. 8(1):39-69.
14. Pinton P, Nougayréde JP, Del Rio JC, Moreno C, Marin DE, Ferrier L, Bracarense AP, Kolf-Clauw M, Oswald IP. 2009. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol. 237(1):41-48.
15. Prelusky DB. 1997. Effect of intraperitoneal infusion of deoxynivalenol on feed consumption and weight gain in the pig. Nat Toxins. 5:121-125.
16. Rotter BA, Prelusky DB, Pestka JJ. 1996. Toxicology of deoxynivalenol (vomitoxin). J Toxicol Environ Health. 48(1):1-34.
17. Sundstol-Eriksen G, Pettersson H. 2003. Lack of deepoxidation of type B trichothecenes in incubates with human faeces. Food Addit Contam. 20:579-582.
18. Turner PC, Hopton R, White KLM, Fisher J, Cade JE, Wild CP. 2011. Assessment of deoxynivalenol metabolite profiles in UK adults. Food Chem Toxicol. 49(1):132-135.
19. Turner PC, Burley VJ, Rothwell JA, White KLM, Cade JE, Wild CP. 2008. Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. J Exposure Sci Env Epidemiol. 18:392-399.
20. Turner PC, Hopton RP, Lecluse Y, White KLM, Fisher J, Lebailly P. 2010. Determinants of urinary deoxynivalenol in male farmers from Normandy, France. J Agri Food Chem. 58(8):5206-5212.
21. Turner PC, Rothwell JA, White KLM, Cade JE, Wild CP. 2008. Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom. Environ Health Perspect. 116:21-25.
22. Turner PC, Taylor F, White KLM, Cade JE, Wild CP. 2009. A comparison of 24 hour urinary deoxynivalenol with recent versus usual cereal consumption for UK adults. Brit J Nutr. 102(9):1276-1279
23. Turner PC, White KLM, Burley V, Hopton R, Rajendram A, Fisher J, Cade JE, Wild CP. 2010. A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults. Biomarkers. 15(6):553-562.
24. Yoshizawa T, Cote LM, Swanson SP, Buck WB. 1986. Confirmation of DOM-1 a de-epoxidation metabolite of deoxynivalenol, in biological fluids of lactating cows. Agric Biol Chem. 50:227-229.
25. Zhang JB, Li HP, Dang FJ, Qu B, Xu YB, Zhao CS, Liao YC. 2007. Determination of the trichothecene mycotoxin chemotypes and associated geographical distribution and phylogenetic species of the Fusarium graminearum clade from China. Mycol Res. 111(8):967-975.
26. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, Li HL, Wen W, Ji BT, Li Q, et al. 2005. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol. 162(11): 1123-1131.